Billionaire Bob Duggan gets CEO help as Summit tests investor interest in $100M offering

Kyle LaHucik

Senior Reporter

Bob Duggan is getting help in the chief executive spot. The billionaire’s title looks a little different as of Tuesday, when Summit Therapeutics COO Maky …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Billionaire Bob Duggan gets CEO help as Summit tests investor interest in $100M offering

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Will CRISPR matter?

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Bil­lion­aire Bob Dug­gan gets CEO help as Sum­mit tests in­vestor in­ter­est in $100M of­fer­ing

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Billionaire Bob Duggan gets CEO help as Summit tests investor interest in $100M offering